Boehringer Ingelheim, a pharmaceuticals maker has agreed to pay (Dollar) 650 million to settle the 4,000 lawsuits related to its blood-thinning drug Pradaxa. "Boehringer Ingelheim announced today that the company has reached a comprehensive settlement of state and federal cases in the US litigation regarding Pradaxa," it said in a statement. Boehringer Ingelheim insisted that it continued to stand behind the drug, which is used to prevent blood clots and stroke ...
via Medindia Health News
More READ
No comments:
Post a Comment